nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD1—Parkinson's disease	0.331	0.444	CbGaD
Propiomazine—DRD2—Parkinson's disease	0.233	0.313	CbGaD
Propiomazine—HTR2A—Parkinson's disease	0.18	0.242	CbGaD
Propiomazine—HTR2A—enteric nervous system—Parkinson's disease	0.00516	0.0597	CbGeAlD
Propiomazine—DRD1—telencephalic ventricle—Parkinson's disease	0.00415	0.0479	CbGeAlD
Propiomazine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00391	0.0452	CbGeAlD
Propiomazine—HTR2A—locus ceruleus—Parkinson's disease	0.00341	0.0394	CbGeAlD
Propiomazine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00322	0.0372	CbGeAlD
Propiomazine—HTR2A—cerebellar cortex—Parkinson's disease	0.00278	0.0321	CbGeAlD
Propiomazine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00269	0.0311	CbGeAlD
Propiomazine—DRD1—nerve—Parkinson's disease	0.00261	0.0302	CbGeAlD
Propiomazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00245	0.0283	CbGeAlD
Propiomazine—HTR2A—pons—Parkinson's disease	0.00196	0.0227	CbGeAlD
Propiomazine—HTR2A—autonomic nervous system—Parkinson's disease	0.00181	0.0209	CbGeAlD
Propiomazine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00162	0.0187	CbGeAlD
Propiomazine—DRD2—nerve—Parkinson's disease	0.00154	0.0179	CbGeAlD
Propiomazine—HTR2A—peripheral nervous system—Parkinson's disease	0.00131	0.0151	CbGeAlD
Propiomazine—ADRA1A—hindbrain—Parkinson's disease	0.00118	0.0136	CbGeAlD
Propiomazine—DRD2—hindbrain—Parkinson's disease	0.00116	0.0134	CbGeAlD
Propiomazine—ADRA1D—forebrain—Parkinson's disease	0.00114	0.0131	CbGeAlD
Propiomazine—DRD1—brainstem—Parkinson's disease	0.00112	0.013	CbGeAlD
Propiomazine—DRD1—forebrain—Parkinson's disease	0.00108	0.0125	CbGeAlD
Propiomazine—HTR2A—nerve—Parkinson's disease	0.00102	0.0118	CbGeAlD
Propiomazine—CHRM4—head—Parkinson's disease	0.000931	0.0108	CbGeAlD
Propiomazine—DRD4—brain—Parkinson's disease	0.000893	0.0103	CbGeAlD
Propiomazine—CHRM4—nervous system—Parkinson's disease	0.000883	0.0102	CbGeAlD
Propiomazine—CHRM2—forebrain—Parkinson's disease	0.000873	0.0101	CbGeAlD
Propiomazine—HTR2C—brainstem—Parkinson's disease	0.000871	0.0101	CbGeAlD
Propiomazine—CHRM4—central nervous system—Parkinson's disease	0.00085	0.00983	CbGeAlD
Propiomazine—HTR2C—forebrain—Parkinson's disease	0.000841	0.00973	CbGeAlD
Propiomazine—CHRM1—forebrain—Parkinson's disease	0.000794	0.00919	CbGeAlD
Propiomazine—HTR2A—hindbrain—Parkinson's disease	0.000763	0.00882	CbGeAlD
Propiomazine—CHRM2—cardiovascular system—Parkinson's disease	0.000738	0.00853	CbGeAlD
Propiomazine—CHRM5—head—Parkinson's disease	0.000728	0.00842	CbGeAlD
Propiomazine—DRD1—midbrain—Parkinson's disease	0.000715	0.00827	CbGeAlD
Propiomazine—CHRM3—forebrain—Parkinson's disease	0.000711	0.00822	CbGeAlD
Propiomazine—CHRM5—nervous system—Parkinson's disease	0.00069	0.00798	CbGeAlD
Propiomazine—ADRA1A—brainstem—Parkinson's disease	0.000676	0.00782	CbGeAlD
Propiomazine—CHRM4—brain—Parkinson's disease	0.000675	0.0078	CbGeAlD
Propiomazine—CHRM1—cardiovascular system—Parkinson's disease	0.000672	0.00777	CbGeAlD
Propiomazine—ADRA1B—head—Parkinson's disease	0.000665	0.00769	CbGeAlD
Propiomazine—CHRM5—central nervous system—Parkinson's disease	0.000664	0.00768	CbGeAlD
Propiomazine—DRD2—brainstem—Parkinson's disease	0.000663	0.00766	CbGeAlD
Propiomazine—ADRA1A—forebrain—Parkinson's disease	0.000653	0.00755	CbGeAlD
Propiomazine—ADRA1D—head—Parkinson's disease	0.000651	0.00752	CbGeAlD
Propiomazine—DRD2—forebrain—Parkinson's disease	0.00064	0.0074	CbGeAlD
Propiomazine—ADRA1B—nervous system—Parkinson's disease	0.000631	0.00729	CbGeAlD
Propiomazine—DRD1—head—Parkinson's disease	0.00062	0.00717	CbGeAlD
Propiomazine—ADRA1D—nervous system—Parkinson's disease	0.000617	0.00713	CbGeAlD
Propiomazine—HTR2C—medulla oblongata—Parkinson's disease	0.000608	0.00703	CbGeAlD
Propiomazine—ADRA1B—central nervous system—Parkinson's disease	0.000607	0.00702	CbGeAlD
Propiomazine—ADRA1D—central nervous system—Parkinson's disease	0.000594	0.00687	CbGeAlD
Propiomazine—DRD1—nervous system—Parkinson's disease	0.000588	0.0068	CbGeAlD
Propiomazine—DRD1—central nervous system—Parkinson's disease	0.000566	0.00654	CbGeAlD
Propiomazine—HTR2C—midbrain—Parkinson's disease	0.000555	0.00642	CbGeAlD
Propiomazine—ADRA1A—cardiovascular system—Parkinson's disease	0.000552	0.00638	CbGeAlD
Propiomazine—HTR2C—spinal cord—Parkinson's disease	0.000542	0.00627	CbGeAlD
Propiomazine—CHRM5—brain—Parkinson's disease	0.000527	0.0061	CbGeAlD
Propiomazine—HRH1—forebrain—Parkinson's disease	0.000505	0.00584	CbGeAlD
Propiomazine—CHRM2—head—Parkinson's disease	0.0005	0.00578	CbGeAlD
Propiomazine—ADRA1B—brain—Parkinson's disease	0.000482	0.00557	CbGeAlD
Propiomazine—HTR2C—head—Parkinson's disease	0.000482	0.00557	CbGeAlD
Propiomazine—HTR2A—embryo—Parkinson's disease	0.000477	0.00552	CbGeAlD
Propiomazine—CHRM2—nervous system—Parkinson's disease	0.000474	0.00548	CbGeAlD
Propiomazine—ADRA1D—brain—Parkinson's disease	0.000471	0.00545	CbGeAlD
Propiomazine—HTR2C—nervous system—Parkinson's disease	0.000457	0.00528	CbGeAlD
Propiomazine—CHRM2—central nervous system—Parkinson's disease	0.000456	0.00527	CbGeAlD
Propiomazine—CHRM1—head—Parkinson's disease	0.000455	0.00526	CbGeAlD
Propiomazine—DRD1—brain—Parkinson's disease	0.000449	0.0052	CbGeAlD
Propiomazine—HTR2C—central nervous system—Parkinson's disease	0.00044	0.00508	CbGeAlD
Propiomazine—HTR2A—brainstem—Parkinson's disease	0.000437	0.00506	CbGeAlD
Propiomazine—CHRM1—nervous system—Parkinson's disease	0.000431	0.00499	CbGeAlD
Propiomazine—DRD2—midbrain—Parkinson's disease	0.000422	0.00488	CbGeAlD
Propiomazine—HTR2A—forebrain—Parkinson's disease	0.000422	0.00488	CbGeAlD
Propiomazine—CHRM1—central nervous system—Parkinson's disease	0.000415	0.0048	CbGeAlD
Propiomazine—CHRM3—head—Parkinson's disease	0.000407	0.00471	CbGeAlD
Propiomazine—CHRM3—nervous system—Parkinson's disease	0.000386	0.00446	CbGeAlD
Propiomazine—ADRA1A—head—Parkinson's disease	0.000374	0.00432	CbGeAlD
Propiomazine—CHRM3—central nervous system—Parkinson's disease	0.000371	0.0043	CbGeAlD
Propiomazine—DRD2—head—Parkinson's disease	0.000366	0.00424	CbGeAlD
Propiomazine—CHRM2—brain—Parkinson's disease	0.000362	0.00419	CbGeAlD
Propiomazine—HTR2A—cardiovascular system—Parkinson's disease	0.000357	0.00413	CbGeAlD
Propiomazine—ADRA1A—nervous system—Parkinson's disease	0.000354	0.0041	CbGeAlD
Propiomazine—HTR2C—brain—Parkinson's disease	0.000349	0.00404	CbGeAlD
Propiomazine—DRD2—nervous system—Parkinson's disease	0.000347	0.00402	CbGeAlD
Propiomazine—ADRA1A—central nervous system—Parkinson's disease	0.000341	0.00394	CbGeAlD
Propiomazine—DRD2—central nervous system—Parkinson's disease	0.000334	0.00387	CbGeAlD
Propiomazine—ADRA1A—cerebellum—Parkinson's disease	0.000333	0.00386	CbGeAlD
Propiomazine—CHRM1—brain—Parkinson's disease	0.00033	0.00381	CbGeAlD
Propiomazine—DRD2—cerebellum—Parkinson's disease	0.000327	0.00378	CbGeAlD
Propiomazine—HTR2A—medulla oblongata—Parkinson's disease	0.000305	0.00353	CbGeAlD
Propiomazine—CHRM3—brain—Parkinson's disease	0.000295	0.00341	CbGeAlD
Propiomazine—HRH1—head—Parkinson's disease	0.000289	0.00334	CbGeAlD
Propiomazine—HTR2A—midbrain—Parkinson's disease	0.000279	0.00322	CbGeAlD
Propiomazine—HRH1—nervous system—Parkinson's disease	0.000274	0.00317	CbGeAlD
Propiomazine—HTR2A—spinal cord—Parkinson's disease	0.000272	0.00314	CbGeAlD
Propiomazine—ADRA1A—brain—Parkinson's disease	0.000271	0.00313	CbGeAlD
Propiomazine—DRD2—brain—Parkinson's disease	0.000265	0.00307	CbGeAlD
Propiomazine—Acetophenazine—DRD1—Parkinson's disease	0.000265	0.0302	CrCbGaD
Propiomazine—HRH1—central nervous system—Parkinson's disease	0.000264	0.00305	CbGeAlD
Propiomazine—HTR2A—head—Parkinson's disease	0.000242	0.00279	CbGeAlD
Propiomazine—Propericiazine—DRD1—Parkinson's disease	0.000234	0.0267	CrCbGaD
Propiomazine—HTR2A—nervous system—Parkinson's disease	0.000229	0.00265	CbGeAlD
Propiomazine—HTR2A—central nervous system—Parkinson's disease	0.000221	0.00255	CbGeAlD
Propiomazine—HTR2A—cerebellum—Parkinson's disease	0.000216	0.00249	CbGeAlD
Propiomazine—HRH1—brain—Parkinson's disease	0.00021	0.00242	CbGeAlD
Propiomazine—Acetophenazine—DRD2—Parkinson's disease	0.000187	0.0213	CrCbGaD
Propiomazine—HTR2A—brain—Parkinson's disease	0.000175	0.00202	CbGeAlD
Propiomazine—Triflupromazine—DRD1—Parkinson's disease	0.000162	0.0185	CrCbGaD
Propiomazine—Clomipramine—GSTP1—Parkinson's disease	0.000151	0.0172	CrCbGaD
Propiomazine—Acepromazine—DRD1—Parkinson's disease	0.00015	0.0171	CrCbGaD
Propiomazine—Thioproperazine—DRD1—Parkinson's disease	0.000147	0.0168	CrCbGaD
Propiomazine—Mesoridazine—DRD3—Parkinson's disease	0.000145	0.0166	CrCbGaD
Propiomazine—Thiothixene—DRD1—Parkinson's disease	0.000145	0.0165	CrCbGaD
Propiomazine—Pipotiazine—DRD1—Parkinson's disease	0.000145	0.0165	CrCbGaD
Propiomazine—Prochlorperazine—DRD3—Parkinson's disease	0.000141	0.016	CrCbGaD
Propiomazine—Cyamemazine—HTR2A—Parkinson's disease	0.000127	0.0145	CrCbGaD
Propiomazine—Fluphenazine—DRD3—Parkinson's disease	0.000127	0.0145	CrCbGaD
Propiomazine—Fluphenazine—DRD1—Parkinson's disease	0.000125	0.0142	CrCbGaD
Propiomazine—Acepromazine—HTR1A—Parkinson's disease	0.000125	0.0142	CrCbGaD
Propiomazine—Thioproperazine—HTR1A—Parkinson's disease	0.000122	0.0139	CrCbGaD
Propiomazine—Thiothixene—HTR1A—Parkinson's disease	0.00012	0.0137	CrCbGaD
Propiomazine—Pipotiazine—HTR1A—Parkinson's disease	0.00012	0.0137	CrCbGaD
Propiomazine—Mesoridazine—HTR1A—Parkinson's disease	0.000118	0.0135	CrCbGaD
Propiomazine—Thioridazine—HTR7—Parkinson's disease	0.000117	0.0133	CrCbGaD
Propiomazine—Chlorprothixene—DRD3—Parkinson's disease	0.000116	0.0132	CrCbGaD
Propiomazine—Triflupromazine—DRD2—Parkinson's disease	0.000115	0.0131	CrCbGaD
Propiomazine—Chlorprothixene—DRD1—Parkinson's disease	0.000114	0.013	CrCbGaD
Propiomazine—Thioridazine—DRD1—Parkinson's disease	0.000108	0.0123	CrCbGaD
Propiomazine—Perphenazine—HTR7—Parkinson's disease	0.000107	0.0122	CrCbGaD
Propiomazine—Acepromazine—DRD2—Parkinson's disease	0.000106	0.0121	CrCbGaD
Propiomazine—Methotrimeprazine—DRD3—Parkinson's disease	0.000105	0.0119	CrCbGaD
Propiomazine—Fluphenazine—HTR1A—Parkinson's disease	0.000104	0.0118	CrCbGaD
Propiomazine—Thioproperazine—DRD2—Parkinson's disease	0.000104	0.0118	CrCbGaD
Propiomazine—Methotrimeprazine—DRD1—Parkinson's disease	0.000103	0.0117	CrCbGaD
Propiomazine—Thiothixene—DRD2—Parkinson's disease	0.000102	0.0116	CrCbGaD
Propiomazine—Pipotiazine—DRD2—Parkinson's disease	0.000102	0.0116	CrCbGaD
Propiomazine—Mequitazine—CYP2D6—Parkinson's disease	0.000101	0.0115	CrCbGaD
Propiomazine—Mesoridazine—DRD2—Parkinson's disease	0.000101	0.0115	CrCbGaD
Propiomazine—Trimipramine—SLC6A3—Parkinson's disease	9.96e-05	0.0114	CrCbGaD
Propiomazine—Perphenazine—DRD1—Parkinson's disease	9.88e-05	0.0113	CrCbGaD
Propiomazine—Prochlorperazine—DRD2—Parkinson's disease	9.74e-05	0.0111	CrCbGaD
Propiomazine—Diltiazem—CYP2D6—Parkinson's disease	9.08e-05	0.0104	CrCbGaD
Propiomazine—Thioridazine—HTR1A—Parkinson's disease	8.94e-05	0.0102	CrCbGaD
Propiomazine—Promazine—DRD1—Parkinson's disease	8.9e-05	0.0102	CrCbGaD
Propiomazine—Fluphenazine—DRD2—Parkinson's disease	8.81e-05	0.01	CrCbGaD
Propiomazine—Trimipramine—HTR1A—Parkinson's disease	8.73e-05	0.00996	CrCbGaD
Propiomazine—Chlorpromazine—HTR7—Parkinson's disease	8.49e-05	0.00968	CrCbGaD
Propiomazine—Fluphenazine—CYP2E1—Parkinson's disease	8.48e-05	0.00967	CrCbGaD
Propiomazine—Trifluoperazine—HTR1A—Parkinson's disease	8.29e-05	0.00946	CrCbGaD
Propiomazine—Perphenazine—HTR1A—Parkinson's disease	8.2e-05	0.00935	CrCbGaD
Propiomazine—Acepromazine—HTR2A—Parkinson's disease	8.19e-05	0.00934	CrCbGaD
Propiomazine—Chlorprothixene—DRD2—Parkinson's disease	8.02e-05	0.00914	CrCbGaD
Propiomazine—Thioproperazine—HTR2A—Parkinson's disease	8e-05	0.00913	CrCbGaD
Propiomazine—Chlorpromazine—DRD3—Parkinson's disease	7.98e-05	0.0091	CrCbGaD
Propiomazine—Thiothixene—HTR2A—Parkinson's disease	7.87e-05	0.00898	CrCbGaD
Propiomazine—Pipotiazine—HTR2A—Parkinson's disease	7.87e-05	0.00898	CrCbGaD
Propiomazine—Chlorpromazine—DRD1—Parkinson's disease	7.83e-05	0.00894	CrCbGaD
Propiomazine—Mesoridazine—HTR2A—Parkinson's disease	7.77e-05	0.00886	CrCbGaD
Propiomazine—Thioridazine—DRD2—Parkinson's disease	7.59e-05	0.00865	CrCbGaD
Propiomazine—Trimipramine—DRD2—Parkinson's disease	7.41e-05	0.00845	CrCbGaD
Propiomazine—Thioridazine—CYP2E1—Parkinson's disease	7.3e-05	0.00833	CrCbGaD
Propiomazine—Methotrimeprazine—DRD2—Parkinson's disease	7.24e-05	0.00826	CrCbGaD
Propiomazine—Thiothixene—CYP2D6—Parkinson's disease	7.2e-05	0.00821	CrCbGaD
Propiomazine—Pipotiazine—CYP2D6—Parkinson's disease	7.2e-05	0.00821	CrCbGaD
Propiomazine—Promethazine—DRD2—Parkinson's disease	7.13e-05	0.00814	CrCbGaD
Propiomazine—Mesoridazine—CYP2D6—Parkinson's disease	7.11e-05	0.0081	CrCbGaD
Propiomazine—Trifluoperazine—DRD2—Parkinson's disease	7.04e-05	0.00803	CrCbGaD
Propiomazine—Methotrimeprazine—CYP2E1—Parkinson's disease	6.97e-05	0.00795	CrCbGaD
Propiomazine—Perphenazine—DRD2—Parkinson's disease	6.96e-05	0.00794	CrCbGaD
Propiomazine—Prochlorperazine—CYP2D6—Parkinson's disease	6.88e-05	0.00785	CrCbGaD
Propiomazine—Fluphenazine—HTR2A—Parkinson's disease	6.8e-05	0.00776	CrCbGaD
Propiomazine—Chlorpromazine—HTR1A—Parkinson's disease	6.51e-05	0.00742	CrCbGaD
Propiomazine—Diltiazem—ABCB1—Parkinson's disease	6.48e-05	0.00739	CrCbGaD
Propiomazine—Promazine—DRD2—Parkinson's disease	6.28e-05	0.00716	CrCbGaD
Propiomazine—Clomipramine—HTR2A—Parkinson's disease	6.22e-05	0.0071	CrCbGaD
Propiomazine—Fluphenazine—CYP2D6—Parkinson's disease	6.22e-05	0.0071	CrCbGaD
Propiomazine—Chlorprothixene—HTR2A—Parkinson's disease	6.2e-05	0.00707	CrCbGaD
Propiomazine—Thioridazine—HTR2A—Parkinson's disease	5.86e-05	0.00669	CrCbGaD
Propiomazine—Triflupromazine—ABCB1—Parkinson's disease	5.78e-05	0.00659	CrCbGaD
Propiomazine—Trimipramine—HTR2A—Parkinson's disease	5.73e-05	0.00653	CrCbGaD
Propiomazine—Clomipramine—CYP2D6—Parkinson's disease	5.69e-05	0.00649	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2A—Parkinson's disease	5.6e-05	0.00638	CrCbGaD
Propiomazine—Chlorpromazine—DRD2—Parkinson's disease	5.52e-05	0.0063	CrCbGaD
Propiomazine—Promethazine—HTR2A—Parkinson's disease	5.51e-05	0.00629	CrCbGaD
Propiomazine—Trifluoperazine—HTR2A—Parkinson's disease	5.44e-05	0.0062	CrCbGaD
Propiomazine—Perphenazine—HTR2A—Parkinson's disease	5.38e-05	0.00614	CrCbGaD
Propiomazine—Thioridazine—CYP2D6—Parkinson's disease	5.36e-05	0.00611	CrCbGaD
Propiomazine—Chlorpromazine—CYP2E1—Parkinson's disease	5.32e-05	0.00606	CrCbGaD
Propiomazine—Trimipramine—CYP2D6—Parkinson's disease	5.24e-05	0.00597	CrCbGaD
Propiomazine—Methotrimeprazine—CYP2D6—Parkinson's disease	5.12e-05	0.00584	CrCbGaD
Propiomazine—Promethazine—CYP2D6—Parkinson's disease	5.04e-05	0.00575	CrCbGaD
Propiomazine—Methadone—CYP2D6—Parkinson's disease	4.96e-05	0.00566	CrCbGaD
Propiomazine—Perphenazine—CYP2D6—Parkinson's disease	4.92e-05	0.00561	CrCbGaD
Propiomazine—Promazine—HTR2A—Parkinson's disease	4.85e-05	0.00553	CrCbGaD
Propiomazine—Fluphenazine—ABCB1—Parkinson's disease	4.44e-05	0.00507	CrCbGaD
Propiomazine—Chlorpromazine—HTR2A—Parkinson's disease	4.27e-05	0.00487	CrCbGaD
Propiomazine—Clomipramine—ABCB1—Parkinson's disease	4.06e-05	0.00463	CrCbGaD
Propiomazine—Chlorprothixene—ABCB1—Parkinson's disease	4.05e-05	0.00461	CrCbGaD
Propiomazine—Chlorpromazine—CYP2D6—Parkinson's disease	3.9e-05	0.00445	CrCbGaD
Propiomazine—Trimipramine—ABCB1—Parkinson's disease	3.74e-05	0.00426	CrCbGaD
Propiomazine—Promethazine—ABCB1—Parkinson's disease	3.6e-05	0.00411	CrCbGaD
Propiomazine—Trifluoperazine—ABCB1—Parkinson's disease	3.55e-05	0.00405	CrCbGaD
Propiomazine—Methadone—ABCB1—Parkinson's disease	3.54e-05	0.00404	CrCbGaD
Propiomazine—Chlorpromazine—ABCB1—Parkinson's disease	2.79e-05	0.00318	CrCbGaD
Propiomazine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.33e-05	8.28e-05	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.32e-05	8.25e-05	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	1.32e-05	8.23e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	1.31e-05	8.16e-05	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.31e-05	8.15e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.3e-05	8.12e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.3e-05	8.12e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.3e-05	8.09e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	1.28e-05	8e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.28e-05	7.99e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.28e-05	7.97e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IGF2—Parkinson's disease	1.28e-05	7.96e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.27e-05	7.95e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—INSR—Parkinson's disease	1.27e-05	7.92e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—CYP2E1—Parkinson's disease	1.26e-05	7.87e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	1.26e-05	7.86e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	1.26e-05	7.84e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	1.25e-05	7.82e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—NQO1—Parkinson's disease	1.25e-05	7.78e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	1.24e-05	7.75e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IGF1R—Parkinson's disease	1.23e-05	7.7e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.23e-05	7.67e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—TH—Parkinson's disease	1.23e-05	7.67e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.23e-05	7.66e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.22e-05	7.63e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EDN1—Parkinson's disease	1.22e-05	7.61e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	1.22e-05	7.59e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.21e-05	7.56e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.21e-05	7.55e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.21e-05	7.54e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	1.21e-05	7.52e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.21e-05	7.52e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.2e-05	7.52e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.2e-05	7.51e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.2e-05	7.51e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	1.2e-05	7.5e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.2e-05	7.5e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.2e-05	7.49e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—FGB—Parkinson's disease	1.2e-05	7.49e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.2e-05	7.47e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	1.2e-05	7.47e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	1.19e-05	7.45e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	1.19e-05	7.41e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.19e-05	7.4e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.19e-05	7.4e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	1.19e-05	7.39e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.18e-05	7.38e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.18e-05	7.38e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	1.18e-05	7.38e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.18e-05	7.37e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—CYCS—Parkinson's disease	1.18e-05	7.36e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.18e-05	7.36e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	1.18e-05	7.36e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	1.18e-05	7.34e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.17e-05	7.32e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.17e-05	7.32e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	1.17e-05	7.27e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	1.16e-05	7.26e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.16e-05	7.26e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	1.16e-05	7.24e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.16e-05	7.24e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.16e-05	7.23e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.16e-05	7.22e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	1.15e-05	7.19e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	1.15e-05	7.19e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	1.15e-05	7.17e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.14e-05	7.14e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	1.14e-05	7.12e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	1.14e-05	7.1e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	1.13e-05	7.07e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.13e-05	7.03e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.12e-05	7.01e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	1.12e-05	7e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	1.12e-05	7e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NGF—Parkinson's disease	1.12e-05	6.99e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	1.12e-05	6.99e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	1.12e-05	6.97e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	1.11e-05	6.93e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	1.11e-05	6.9e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NGF—Parkinson's disease	1.11e-05	6.9e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	1.1e-05	6.88e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	1.1e-05	6.85e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	1.1e-05	6.84e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	1.08e-05	6.76e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.07e-05	6.67e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	1.07e-05	6.65e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NGF—Parkinson's disease	1.06e-05	6.6e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	1.05e-05	6.57e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.05e-05	6.56e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.05e-05	6.55e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	1.05e-05	6.53e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—COMT—Parkinson's disease	1.04e-05	6.52e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	1.04e-05	6.51e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GSTP1—Parkinson's disease	1.04e-05	6.49e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—MAOA—Parkinson's disease	1.04e-05	6.47e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.04e-05	6.46e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	1.03e-05	6.44e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.03e-05	6.42e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—HMOX1—Parkinson's disease	1.03e-05	6.4e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.02e-05	6.35e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.02e-05	6.35e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.02e-05	6.34e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.02e-05	6.34e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	1.01e-05	6.32e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	1.01e-05	6.32e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	1.01e-05	6.3e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	1.01e-05	6.3e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NGF—Parkinson's disease	1.01e-05	6.29e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	1.01e-05	6.29e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	1e-05	6.24e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	1e-05	6.24e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	9.97e-06	6.22e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	9.97e-06	6.22e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	9.95e-06	6.21e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—APOE—Parkinson's disease	9.92e-06	6.19e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ABCB1—Parkinson's disease	9.84e-06	6.14e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	9.83e-06	6.13e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—APOE—Parkinson's disease	9.78e-06	6.1e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	9.6e-06	5.99e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GSTM1—Parkinson's disease	9.56e-06	5.96e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	9.5e-06	5.93e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	9.47e-06	5.91e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	9.41e-06	5.87e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	9.39e-06	5.86e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	9.37e-06	5.84e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GPX1—Parkinson's disease	9.15e-06	5.71e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	9.1e-06	5.68e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	8.99e-06	5.61e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—APOE—Parkinson's disease	8.93e-06	5.57e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	8.81e-06	5.5e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	8.67e-06	5.41e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	8.63e-06	5.38e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	8.53e-06	5.33e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	8.52e-06	5.31e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	8.49e-06	5.3e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—INS—Parkinson's disease	8.47e-06	5.29e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	8.46e-06	5.28e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—MTHFR—Parkinson's disease	8.45e-06	5.27e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	8.39e-06	5.23e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	8.38e-06	5.23e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—INS—Parkinson's disease	8.36e-06	5.21e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	8.36e-06	5.21e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	8.29e-06	5.17e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	8.26e-06	5.15e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	8.25e-06	5.15e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	8.23e-06	5.14e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	8.21e-06	5.13e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	8.21e-06	5.12e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	8.18e-06	5.1e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	8.15e-06	5.09e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	8.14e-06	5.08e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	8.11e-06	5.06e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	8.1e-06	5.06e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	8.08e-06	5.04e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	8.08e-06	5.04e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	8.01e-06	5e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—INS—Parkinson's disease	8e-06	4.99e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	7.98e-06	4.98e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	7.86e-06	4.91e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—APOE—Parkinson's disease	7.86e-06	4.91e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	7.64e-06	4.76e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—INS—Parkinson's disease	7.63e-06	4.76e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	7.62e-06	4.75e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	7.52e-06	4.69e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	7.49e-06	4.68e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NGF—Parkinson's disease	7.48e-06	4.67e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	7.45e-06	4.65e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	7.43e-06	4.64e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	7.36e-06	4.59e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	7.34e-06	4.58e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	7.31e-06	4.56e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	7.25e-06	4.52e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	7.12e-06	4.44e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	7.09e-06	4.43e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	7.07e-06	4.41e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	7e-06	4.37e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	6.98e-06	4.36e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	6.74e-06	4.21e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—INS—Parkinson's disease	6.72e-06	4.19e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	6.63e-06	4.14e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—APOE—Parkinson's disease	6.62e-06	4.13e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	6.6e-06	4.12e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	6.57e-06	4.1e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—INS—Parkinson's disease	6.52e-06	4.07e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	6.51e-06	4.06e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	6.49e-06	4.05e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CASP3—Parkinson's disease	6.31e-06	3.94e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL6—Parkinson's disease	6.27e-06	3.91e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	6.25e-06	3.9e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	6.22e-06	3.88e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	6.18e-06	3.86e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	5.96e-06	3.72e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	5.92e-06	3.69e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	5.8e-06	3.62e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—INS—Parkinson's disease	5.76e-06	3.59e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	5.72e-06	3.57e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	5.68e-06	3.54e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—INS—Parkinson's disease	5.67e-06	3.53e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—INS—Parkinson's disease	5.65e-06	3.53e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	5.64e-06	3.52e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—INS—Parkinson's disease	5.63e-06	3.52e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—INS—Parkinson's disease	5.62e-06	3.5e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	5.6e-06	3.5e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	5.57e-06	3.47e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	5.56e-06	3.47e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	5.55e-06	3.46e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	5.48e-06	3.42e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	5.22e-06	3.26e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	5.15e-06	3.21e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	4.86e-06	3.03e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	4.83e-06	3.01e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	4.65e-06	2.9e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	4.62e-06	2.88e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.46e-06	2.79e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	4.29e-06	2.67e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	4.27e-06	2.67e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	4.26e-06	2.66e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	4.22e-06	2.63e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	4.21e-06	2.63e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	4.2e-06	2.62e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	4.19e-06	2.61e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	4.18e-06	2.61e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	4.18e-06	2.61e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	4.17e-06	2.6e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	4.15e-06	2.59e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	4.14e-06	2.58e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	4.13e-06	2.58e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	4.11e-06	2.57e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	4.1e-06	2.56e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.94e-06	2.46e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.88e-06	2.42e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	3.87e-06	2.41e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.86e-06	2.41e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	3.84e-06	2.4e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	3.81e-06	2.37e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	3.8e-06	2.37e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—Parkinson's disease	3.7e-06	2.31e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	3.65e-06	2.28e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	3.5e-06	2.18e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—Parkinson's disease	3.33e-06	2.08e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	3.29e-06	2.05e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.85e-06	1.78e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.73e-06	1.7e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.48e-06	1.54e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—Parkinson's disease	2.47e-06	1.54e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	2.46e-06	1.54e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	2.45e-06	1.53e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	2.43e-06	1.52e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	2.42e-06	1.51e-05	CbGpPWpGaD
